David A. Hosford

2012

In 2012, David A. Hosford earned a total compensation of $520.2K as Vice President, Clinical Development and Regulatory Affairs at Catalyst Biosciences.

Compensation breakdown

Bonus$10,132
Non-Equity Incentive Plan$3,377
Option Awards$226,493
Salary$270,180
Other$10,000
Total$520,182

Hosford received $270.2K in salary, accounting for 52% of the total pay in 2012.

Hosford also received $10.1K in bonus, $3.4K in non-equity incentive plan, $226.5K in option awards and $10K in other compensation.

Rankings

In 2012, David A. Hosford's compensation ranked 8,642nd out of 11,487 executives tracked by ExecPay. In other words, Hosford earned more than 24.8% of executives.

ClassificationRankingPercentile
All
8,642
out of 11,487
25th
Division
Manufacturing
3,137
out of 4,253
26th
Major group
Chemicals And Allied Products
838
out of 1,198
30th
Industry group
Drugs
613
out of 920
33rd
Industry
Pharmaceutical Preparations
480
out of 700
31st
Source: SEC filing on April 18, 2014.

Hosford's colleagues

We found six more compensation records of executives who worked with David A. Hosford at Catalyst Biosciences in 2012.

2012

Stephen Hill

Catalyst Biosciences

Chief Executive Officer

2012

Jeffrey Brennan

Catalyst Biosciences

Former Senior Vice President, Business and Commercial Development and Chief Business Officer

2012

Alan Musso

Catalyst Biosciences

Chief Financial Officer

2012

Peter Zorn

Catalyst Biosciences

General Counsel

2012

J deBethizy

Catalyst Biosciences

Chief Executive Officer

2012

Mark Skaletsky

Catalyst Biosciences

Chairman

You may also like